Drugs Made In America Acquisition Corp.
dmaacorp.comWhat Do They Do?
Seeks to combine with a business, with a stated focus on artificial intelligence, pharmaceuticals, and other fields needing rapid innovation.
10-K for FY2025, filed Apr 15, 2026We are a blank check company incorporated in the Cayman Islands as an exempted company for the purpose of effecting a merger, share…View ↗
While we may pursue an acquisition opportunity in any industry or sector and in any region, we intend to focus on industries that…View ↗
Our acquisition and value creation strategy is to identify, acquire and, after our initial business combination, further accelerate the…View ↗
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Apr 15, 2026
How Are They Changing?
-
Sep 8, 2026
Restated the merger agreement with Power Analytics as a single-target deal
PAGC is expected to acquire APQC before the merger closes, and completing that acquisition is a condition to DMAA’s obligation to close.
Sources
8-K, filed Sep 14, 2026
On September 8, 2026, following approval by the Company’s board of directors (the “Board”), the Company and PAGC entered into an Amended…View ↗
-
Jul 20, 2026
Amended merger terms covering founder shares, public rights and cash requirements
The amendment revised founder-share terms, required a tender offer or other treatment for public rights, and reset minimum-cash provisions.
Sources
8-K, filed Jul 20, 2026
The Company agreed to: (i) cause the former sponsor entity to forfeit not less than 50% of the founder shares held by it and cause the…View ↗
-
May 5, 2026
Agreed to merge with Power Analytics Global
PAGC would merge with DMAA or a subsidiary; closing requires shareholder approval, an effective registration statement and satisfaction of other conditions.
Sources
8-K, filed May 5, 2026
On April 29, 2026, Drugs Made In America Acquisition Corp., a Cayman Islands exempted company (the “Company” or “DMAA”), entered into a…View ↗
Loading...
